Document Type

Journal Article

Publication Title

Veterinary Sciences








School of Science




American College of Veterinary Emergency and Critical Care (Grant number AC019) / Murdoch University Veterinary Life Sciences Small Grant / Intensive Care Foundation of Australia and New Zealand (Trainee Grant) / Metabolomics Australia, a BPA funded initiative, through the National Collaborative Research Infrastructure Strategy / Murdoch University Research Training Program Scholarship


Claus, M. A., Smart, L., Raisis, A. L., Sharp, C. R., Abraham, S., Gummer, J. P., ... & Litton, E. (2023). Effect of deferoxamine on post-transfusion iron, inflammation, and in vitro microbial growth in a canine hemorrhagic shock model: A randomized controlled blinded pilot study. Veterinary Sciences, 10(2), Article 121.


Red blood cell (RBC) transfusion is associated with recipient inflammation and infection, which may be triggered by excessive circulating iron. Iron chelation following transfusion may reduce these risks. The aim of this study was to evaluate the effect of deferoxamine on circulating iron and inflammation biomarkers over time and in vitro growth of Escherichia coli (E. coli) following RBC transfusion in dogs with atraumatic hemorrhage. Anesthetized dogs were subject to atraumatic hemorrhage and transfusion of RBCs, then randomized to receive either deferoxamine or saline placebo of equivalent volume (n = 10 per group) in a blinded fashion. Blood was sampled before hemorrhage and then 2, 4, and 6 h later. Following hemorrhage and RBC transfusion, free iron increased in all dogs over time (both p < 0.001). Inflammation biomarkers interleukin-6 (IL6), CXC motif chemokine-8 (CXCL8), interleukin-10 (IL10), and keratinocyte-derived chemokine (KC) increased in all dogs over time (all p < 0.001). Logarithmic growth of E. coli clones within blood collected 6 h post-transfusion was not different between groups. Only total iron-binding capacity was different between groups over time, being significantly increased in the deferoxamine group at 2 and 4 h post-transfusion (both p < 0.001). In summary, while free iron and inflammation biomarkers increased post-RBC transfusion, deferoxamine administration did not impact circulating free iron, inflammation biomarkers, or in vitro growth of E. coli when compared with placebo.



Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.